Vancomycin-resistant Enterococcus: Risk factors, surveillance, infections, and treatment

Keyphrases

• Risk Treatment 100%
• Risk-based Surveillance 100%
• Vancomycin-resistant Enterococcus Faecium (VREfm) 100%
• Patient Characteristics 33%
• Enterococcus 33%
• Vancomycin 33%
• Methicillin-resistant Staphylococcus Aureus 33%
• Current Treatment 33%
• Treatment Strategy 33%
• Nosocomial Infection 33%
• Transmission Mode 33%
• English Language 33%
• Surgical Patients 33%
• Enterococcus Spp 33%
• Looming 33%
• Vancomycin-resistant S. Aureus 33%
• Genetic Transfer 33%
• Major Threat 33%
• Patient numbers 33%
• Review Methods 33%

Medicine and Dentistry

• Infection 100%
• Risk Factor Surveillance 100%
• Vancomycin Resistant Enterococcus 100%
• Vancomycin 66%
• Prevalence 33%
• Hospital Infection 33%
• Staphylococcus Aureus 33%
• Gene Transfer 33%
• Methicillin Resistant Staphylococcus Aureus 33%
• English (Language) 33%
• Enterococcus 33%

Immunology and Microbiology

• Infectious Disease 100%
• Vancomycin-Resistant Enterococcus 100%
• Infection 100%
• Prevalence 33%
• Gene Transfer 33%
• Methicillin-Resistant Staphylococcus Aureus 33%
• Staphylococcus Aureus 33%
• Enterococcus 33%